Olli Kallioniemi

机构：University of Helsinki, Science for Life Laboratory, Karolinska Institutet, Institute for Molecular Medicine Finland, HiLIFE – Elämäntieteiden Instituutti · ORCID：0000-0002-3231-0332

发表论文 962 篇 · 总被引 63700 次 · h-index 123

代表论文

• Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism (2025 · Cell Death and Disease · 被引 9)
• Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities (2025 · Cell Death Discovery · 被引 8)
• Evaluating feature extraction in ovarian cancer cell line co-cultures using deep neural networks (2025 · Communications Biology · 被引 5)
• Fibroblast Activation Protein Defines an Aggressive, Immunosuppressive EMT-associated Tumor Subtype in Highly Inflamed Localized Clear Cell Renal Cell Carcinoma (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 5)
• Pathway activation model for personalized prediction of drug synergy (2025 · eLife · 被引 4)
• MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response (2025 · Cancer Gene Therapy · 被引 3)